17OH11MT

17OH11MT is a chemical compound that belongs to the class of synthetic cannabinoids, which are man-made substances designed to mimic the effects of the natural cannabinoids found in the cannabis plant. The chemical name for 17OH11MT is (1R,6R)-6-(4-fluorophenyl)-1-hydroxy-N-(1-naphthalenylmethyl)-1,6-dihydropyrazino[1,2-a]indole-3-carboxamide. It was first synthesized in 2012 by a research group led by Dr. John W. Huffman at the University of Mississippi.

17OH11MT is known for its potent psychoactive effects, which include euphoria, altered perception, and increased heart rate. It is often sold as a designer drug, with various street names such as "Mamba," "Huffman," and "Huffy." The compound is typically ingested in the form of pills, powders, or liquids, and its effects can last for several hours.

Due to its potent nature and the lack of regulatory oversight, 17OH11MT has been associated with a range of adverse effects, including anxiety, paranoia, and cardiovascular issues. In some cases, it has also been linked to more severe health problems, such as psychosis and heart attacks. As a result, 17OH11MT is classified as a controlled substance in many countries, including the United States, where it is a Schedule I drug under the Controlled Substances Act.

The synthesis and distribution of 17OH11MT are illegal in many jurisdictions, and its use is strongly discouraged due to the potential risks to health and safety. Individuals who are considering using synthetic cannabinoids should be aware of the dangers associated with these substances and seek help if needed.